arrow
S

Salvador Jaime-Casas

city of hope comprehensive cancer center
H指数:6
被引数:160

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating Worldwide Disparities in Bladder Cancer Clinical Trial Availability

评估全球范围内膀胱癌临床试验可及性的差异

Cancers
IF4.4
2026-05-270
OA
Disparities in Outcomes in Latino Subpopulations with Localized Prostate Cancer Undergoing Radical Prostatectomy: A Population-Based Analysis

局部前列腺癌行根治性前列腺切除术的拉丁裔亚人群结局差异:一项基于人群的分析

Cancers
IF4.4
2026-04-030
OAAI
Efficacy of sacituzumab govitecan after enfortumab vedotin in advanced urothelial carcinoma: Analysis of the UNITE study

在恩沃利单抗之后的尿路上皮癌患者中,萨cituzumab govitecan的疗效:UNITE研究的分析

2025-12-010
OAAI
Clinical Predictors and Prognostic Significance of Pathologic Disease Upstaging at Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer

肌层浸润性膀胱癌患者根治性膀胱切除术中病理疾病升级的临床预测因素及预后意义

2025-10-090
OA
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinoma

抗体药物偶联物联合疗法在晚期尿路上皮癌中的疗效与安全性

2025-10-070
OAAI
Evaluation of Long-Term Outcomes Utilizing Indocyanine Green to Decrease Ureteroenteric Anastomotic Stricture During Robotic Radical Cystectomy and Extracorporeal Urinary Diversion

利用吲哚菁绿减少机器人根治性膀胱切除术及体外尿流改道术中输尿肠吻合口狭窄的长期疗效评估

2025-09-190
OAAI
Clinical and Pathological Predictors for Occult Lymph Node Involvement in Patients With Clinical Node-Negative Bladder Cancer Undergoing Radical Cystectomy

临床和病理学预测因子:在接受根治性膀胱切除术的临床淋巴结阴性的膀胱癌患者中 occult 淋巴结受累的预测因子

2025-09-010
PRE
Trends in Surgical Overtreatment of Prostate Cancer

前列腺癌手术过度治疗的趋势

2025-04-280
PRE
Impact of Latino ethnicity on the gut microbiome and response to immune checkpoint inhibition (ICI) with CBM588 in patients (pts) with metastatic renal cell cancer (mRCC)

拉美裔族裔对肠道微生物组和接受CBM588治疗的免疫检查点抑制剂(ICI)反应的影响,在转移性肾细胞癌(mRCC)患者(pts)中的研究

2024-09-010
PRE
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

卡博替尼和nivolumab联合或不联合活细菌补充治疗转移性肾细胞癌: 一项随机1期试验

2024-06-285
OAAI